ArticleBMC oral health2025
Corticosteroid injection for pyogenic granuloma of the tongue in a rare resembling ulcerative malignancy: a case report.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPyogenic granuloma (PG) is a benign vasoproliferative lesion that usually occurs in the skin And mucosa. The clinical manifestations of PG are rapid growth, pedicled or broad base of a single red smooth papule, easily bleeding with minor lesions. Most of the oral lesions occur at the gingiva, And the extra-gingival lesions is less common, and the ulcerative type is even rarer. We present a case of ulcerative lesion located at the lateral margin of the tongue with a peripheral bulge for more than 5 years. It was initially suspected to be tongue cancer and was confirmed to be a PG by microscopic examination, and the ulcer healed and the protrusion subsided after topical steroid corticosteroid injection. CASE PRESENTATION: A 75-year-old woman presented with An ulcer on the right tongue for more than 5 years. Clinical examination revealed a prominence seen on the mid-posterior part of the lateral margin of the right tongue with a tough texture and an ulcerated surface visible in the center. The Lingual cusps of the right lower first And second molars opposite the ulcer was sharp. Interestingly, the patient had undergone partial gastrointestinal resection because of gastric carcinoma And had been on antidepressants for 4 years. Hematoxylin-eosin (HE) staining was suggestive of vascular and vascular endothelial cell hyperplasia in the lamina propria of the ulcer surface, and the pathologic diagnosis was PG. Two injections of triamcinolone acetonide acetate (mixed with lidocaine hydrochloride) were administered at 2-week intervals, combined with topical bovine basic fibroblast growth factor (bFGF) and cetylpyridinium chloride/compound chlorhexidine gargle. Complete healing was observed at 4 weeks, with no recurrence confirmed by telephone follow-up at 6-month and1-year post-treatment. DISCUSSION: Extragingival PGs in the mouth are relatively rare, and longstanding ulcerative protrusions occurring on the lateral margins of the tongue are often recognized as ulcerative tumors, and pathology is necessary to distinguish malignant tumors from PGs. Trauma, altered hormone levels, and medications can all contribute to the development of PGs, and we hypothesize that the sharp dental cusps, altered estrogen secretion, long-term use of antidepressant medications, and partial gastrointestinal resection may contributed to the development of PG in this woman. The conventional treatment for PG is surgical resection. In this case, good therapeutic effect was achieved after using multi-point topical injection of corticosteroid, combined with wet compress, mouthwash, and medication application, which provides clinical basis for the selection of non-surgical treatment for PG.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.